First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center
PR Newswire —
- Trial investigates the FDA Breakthrough device "Tumor Monorail," a paradigm-shifting approach for tracking and treating recurring glioblastoma, one of the deadliest cancers, in real time - DURHAM, N.C., Jan. 6, 2026 /PRNewswire/ -- Exvade Bioscience™, a clinical-stage neuro-oncology...